23 related articles for article (PubMed ID: 6401212)
1. Fate of intravenously administered rat lymphokine-activated killer cells labeled with different markers.
Maghazachi AA; Fitzgibbon L
Cancer Immunol Immunother; 1990; 31(3):139-45. PubMed ID: 2337903
[TBL] [Abstract][Full Text] [Related]
2. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.
Montrucchio G; Alloatti G; Mariano F; de Paulis R; Comino A; Emanuelli G; Camussi G
Am J Pathol; 1990 Jul; 137(1):71-83. PubMed ID: 2372044
[TBL] [Abstract][Full Text] [Related]
3. Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose.
Scheffel U; Tsan MF; Mitchell TG; Camargo EE; Braine H; Ezekowitz MD; Nickoloff EL; Hill-Zobel R; Murphy E; McIntyre PA
J Nucl Med; 1982 Feb; 23(2):149-56. PubMed ID: 6799622
[TBL] [Abstract][Full Text] [Related]
4. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
Wiltrout RH; Gorelik E; Brunda MJ; Holden HT; Herberman RB
Cancer Immunol Immunother; 1983; 14(3):172-9. PubMed ID: 6404550
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, distribution, and sites of destruction of canine blood platelets with In-111 oxine.
Lötter MG; Badenhorst PN; Heyns AD; Van Reenen OR; Pieters H; Minnaar PC
J Nucl Med; 1980 Jan; 21(1):36-40. PubMed ID: 6766182
[TBL] [Abstract][Full Text] [Related]
6. An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets.
Wessels P; Heyns AD; Pieters H; Lötter MG; Badenhorst PN
Eur J Nucl Med; 1985; 10(11-12):522-7. PubMed ID: 3928383
[TBL] [Abstract][Full Text] [Related]
7. Comparison of oxine and tropolone methods for labeling human platelets with indium-111.
Kotzé HF; Heyns AD; Lötter MG; Pieters H; Roodt JP; Sweetlove MA; Badenhorst PN
J Nucl Med; 1991 Jan; 32(1):62-6. PubMed ID: 1899112
[TBL] [Abstract][Full Text] [Related]
8. 111In oxine-labeled rabbit platelets: in vivo distribution and sites of destruction.
Hill-Zobel RL; Scheffel U; McIntyre PA; Tsan MF
Blood; 1983 Jan; 61(1):149-53. PubMed ID: 6401212
[TBL] [Abstract][Full Text] [Related]
9. Platelet kinetics with indium-111 platelets: comparison with chromium-51 platelets.
Peters AM; Lavender JP
Semin Thromb Hemost; 1983 Apr; 9(2):100-14. PubMed ID: 6346489
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of indium-111 labeled blood products.
Loken MK; Clay ME; Carpenter RT; Boudreau RJ; McCullough JJ
Clin Nucl Med; 1985 Dec; 10(12):902-11. PubMed ID: 3935355
[TBL] [Abstract][Full Text] [Related]
11. Platelet survival studies. An overview of the factors affecting the efficiency and reliability of platelet radiolabeling.
Kelton JG
Transfusion; 1986; 26(1):19-22. PubMed ID: 3080828
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
